Literature DB >> 28919255

SUMO proteins: Guardians of immune system.

Sabrina Adorisio1, Alessandra Fierabracci2, Isabella Muscari3, Anna Marina Liberati3, Emira Ayroldi1, Graziella Migliorati1, Trinh Thi Thuy4, Carlo Riccardi1, Domenico V Delfino5.   

Abstract

Small ubiquitin-like modifier (SUMO) proteins belong to the ubiquitin-like family and act to change the function of target proteins through post-translational modifications. Through their interactions with innate immune pathways, SUMOs promote an efficient immune response to pathogenic challenge avoiding, at the same time, an excess of immune response that could lead to the development of autoimmune diseases. This report discusses the general functions of SUMO proteins; highlights SUMO involvement in the innate immune response through their role in NF-κB and interferon pathways; the involvement of SUMO proteins in autoimmune diseases; and reviews bacterial, viral, and parasitic interactions with SUMO pathways. In conclusion, we speculate that targeting SUMOs could represent a new therapeutic strategy against infections and autoimmunity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Innate immune system; Interferon pathway; NF-κB pathway; Small ubiquitin-like modifier (SUMO) proteins

Mesh:

Substances:

Year:  2017        PMID: 28919255     DOI: 10.1016/j.jaut.2017.09.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  16 in total

1.  SUMO conjugation regulates immune signalling.

Authors:  Sushmitha Hegde; Amarendranath Soory; Bhagyashree Kaduskar; Girish S Ratnaparkhi
Journal:  Fly (Austin)       Date:  2020-08-31       Impact factor: 2.160

Review 2.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Sumoylation in Physiology, Pathology and Therapy.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

Review 4.  Rhabdoviruses, Antiviral Defense, and SUMO Pathway.

Authors:  Faten El Asmi; Carlos Eduardo Brantis-de-Carvalho; Danielle Blondel; Mounira K Chelbi-Alix
Journal:  Viruses       Date:  2018-12-03       Impact factor: 5.048

5.  Different SUMO paralogues determine the fate of wild-type and mutant CFTRs: biogenesis versus degradation.

Authors:  Xiaoyan Gong; Yong Liao; Annette Ahner; Mads Breum Larsen; Xiaohui Wang; Carol A Bertrand; Raymond A Frizzell
Journal:  Mol Biol Cell       Date:  2018-11-07       Impact factor: 4.138

Review 6.  The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis.

Authors:  Sajad Dehnavi; Mahvash Sadeghi; Peter E Penson; Maciej Banach; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

Review 7.  Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway.

Authors:  Yuki Nakamori; Eun Jeong Park; Motomu Shimaoka
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

Review 8.  The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases.

Authors:  Jinlin Liu; Li Zhong; Rui Guo
Journal:  Oxid Med Cell Longev       Date:  2021-02-18       Impact factor: 6.543

Review 9.  Ubiquitination as an Important Host-Immune Response Strategy in Penaeid Shrimp: Inferences From Other Species.

Authors:  Zhaoxue Zhang; Jude Juventus Aweya; Defu Yao; Zhihong Zheng; Ngoc Tuan Tran; Shengkang Li; Yueling Zhang
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

Review 10.  SUMO and SUMOylation Pathway at the Forefront of Host Immune Response.

Authors:  Sajeev T K; Garima Joshi; Pooja Arya; Vibhuti Mahajan; Akanksha Chaturvedi; Ram Kumar Mishra
Journal:  Front Cell Dev Biol       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.